ReviewViruses2022

A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment.

Daniele Focosi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.